Boosting The Intervention Effect of Negative Memory Through tACS Stimulation
NCT ID: NCT06375395
Last Updated: 2024-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2024-08-15
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
tACS Improves Memory in Elders With Subjective Memory Complaints
NCT05569902
Memory Functions in Mild Alzheimer's Disease
NCT04785053
Effects of Brain-stimulation on Metamemory Monitoring and Control
NCT03693729
Effects of tACS Combined With CCT for Patients With MCI
NCT04135742
Improvement of Memory in Mild Cognitive Impairment
NCT05708001
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A 5-day memory updating experimental paradigm is used.
1. On the first day, the old memory A-B linkage is learned, where A represents a neutral word and B is either neutral or negative pictures (half of each, randomly scrambled).
2. On the second day, the old memory A-B association is consolidated again, and after a 15-minute break, the new memory A-C association is learned, where A is still the word A used in the old memory A-B association on the first day, and C is the new neutral and negative pictures (half of each, randomly scrambled, and with inconsistent categories of C and B in each pair of AC and AB). Immediately following this, the new memories of the A-C conjunctions are updated using both Retrieval practice and Restudy (control condition) memory strategies.
3. A-C is extracted/learned using both Retrieval practice and Restudy memory strategies on both day 3 and day 4.
4. On the fifth day, memory tests for associative memory strength, gist and detail memory, as well as emotional valence and strength are performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active tACS
Those who participate in the treatment group will receive tACS, which lasts for 40 minutes per day on 3 consecutive days.
Active tACS Device
Transcranial Alternating Current Stimulation
Sham tACS
Those who participate in the control group will receive sham tACS, which lasts for 40 minutes per day on 3 consecutive days.
Sham tACS Device
Placebo Device that simulates active tACS treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active tACS Device
Transcranial Alternating Current Stimulation
Sham tACS Device
Placebo Device that simulates active tACS treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Drug-resistant epilepsy;
3. Required surgical implantation of SEEG electrodes.
Exclusion Criteria
2. Significant heart, liver, renal insufficiency, and other medical diseases;
3. Severe side effects from taking antiepileptic drugs at the time of enrollment and not inappropriate for SEEG;
4. Significant intellectual disability;
5. A history of alcohol and drug abuse;
6. Any contraindication to MRI.
14 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Normal University
OTHER
Xuanwu Hospital, Beijing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guoguang Zhao
Role: STUDY_DIRECTOR
Xuanwu Hospital, Beijing
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Memory Updating Tasks
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.